BMY Up 7.6% Post Q4 Earnings: Should You Buy, Sell or Hold the Stock?Zacks Investment Research • 02/09/26
Evinova and Bristol Myers Squibb Forge Strategic Collaboration to Optimize Clinical Development with Artificial IntelligenceBusiness Wire • 02/09/26
Bristol-Myers Stock Up as Q4 Earnings and Revenues Beat EstimatesZacks Investment Research • 02/05/26
Bristol Myers Just Crushed Earnings, and the Real Catalyst Hasn't Even Hit Yet24/7 Wall Street • 02/05/26
Bristol Myers (BMY) Reports Q4 Earnings: What Key Metrics Have to SayZacks Investment Research • 02/05/26
Bristol Myers Squibb (BMY) Tops Q4 Earnings and Revenue EstimatesZacks Investment Research • 02/05/26
Bristol Myers Rises Inside A Buy Zone On Street-Beating 2026 OutlookInvestors Business Daily • 02/05/26
Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2025Business Wire • 02/05/26
OXB Signs New Multi-Year Commercial Supply Agreement with Bristol Myers SquibbGlobeNewsWire • 02/04/26
Bristol Myers Squibb Teams Up with Kasey Keller to Share His Lymphoma Journey with BreyanziBusiness Wire • 02/04/26
Unveiling Bristol Myers (BMY) Q4 Outlook: Wall Street Estimates for Key MetricsZacks Investment Research • 02/02/26